Department of Psychosomatic Medicine and Psychotherapy, Klinikum rechts der Isar, Technische Unversität München, München, Germany.
Behav Med. 2012 Jan;38(1):1-5. doi: 10.1080/08964289.2011.640364.
Prior work demonstrated that cognitive-behavioral (CBT) and supportive-experiential (SET) group interventions can reduce dysfunctional fear of progression (FoP) in patients with chronic diseases. In this secondary analysis of a randomized controlled study, we investigated determinants of long-term response to group therapy for FoP. Response to therapy after 12 months was assessed using the Reliable Change Index (RCI). Outcome data were available for 129 patients with cancer and 116 patients with chronic arthritis. 37.9% of the patients in the CBT group and 32.7% of those attending the SET group indicated response to therapy (p=.402). Educational level predicted long-term response to therapy (OR 2.53, 95% CI 1.33-4.81; p=.005). Medical patients with lower education may need additional attention in order to gain long-lasting benefit from brief group psychotherapy. However, this investigation needs to be replicated in a study that includes a broader range of psychological predictors.
先前的研究表明，认知行为（CBT）和支持体验（SET）团体干预可以减少慢性疾病患者的功能失调性进展恐惧（FoP）。在这项随机对照研究的二次分析中，我们研究了团体治疗 FoP 长期反应的决定因素。使用可靠变化指数（RCI）评估 12 个月后的治疗反应。癌症患者的结局数据为 129 例，慢性关节炎患者为 116 例。CBT 组的 37.9%和 SET 组的 32.7%患者表示对治疗有反应（p=.402）。教育水平预测了治疗的长期反应（OR 2.53，95%CI 1.33-4.81；p=.005）。教育程度较低的医学患者可能需要额外的关注，以便从简短的团体心理治疗中获得持久的益处。然而，这一发现需要在一项包含更广泛心理预测因素的研究中得到复制。
